Ph.D. Dinesh V Patel - 26 Apr 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
President and CEO, Director
Signature
/s/ Dinesh V. Patel, Ph.D.
Issuer symbol
PTGX
Transactions as of
26 Apr 2022
Net transactions value
+$126,300
Form type
4
Filing time
26 Apr 2022, 21:34:11 UTC
Previous filing
14 Apr 2022
Next filing
04 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $126,300 +30,000 +5.6% $4.21* 568,306 26 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -30,000 -24% $0.000000 95,742 26 Apr 2022 Common Stock 30,000 $4.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 459 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2022.
F2 The stock option is vested in full.

Remarks:

Exhibit 24 - Power of Attorney